GL1X · GenesisL1 explorer

MolNFT v1 · #67773 · protein

Crystal structure of pantothenate synthetase in complex with 2-(5- methoxy-2-(5-methylpyridin-2-ylsulfonylcarbamoyl)-1H-indol-1-yl) acetic acid

3IUE: “Crystal structure of pantothenate synthetase in complex with 2-(5…”. X-ray diffraction, 1 ligand (FG3), 5 pockets (best druggability 0.83). MolNFT v1 #67773 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3IUE
Type
protein
Length
566 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pantothenate synthetase
EC
6.3.2.1
UniProt
P0A5R0
Ligands
FG3
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APantothenate synthetase (EC 6.3.2.1)protein28841% helix, 23% strandP0A5R0
BPantothenate synthetase (EC 6.3.2.1)protein27841% helix, 24% strandP0A5R0

Ligands and binding sites

  • FG3 · (5-methoxy-2-{[(5-methylpyridin-2-yl)sulfonyl]carbamoyl}-1H-indol-1-yl)acetic acid · ligand · 3 copies · chains A, B
  • GOL · Glycerol · additive · 7 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 7 copies · chains A, B
  • EOH · Ethanol · additive · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15640.830.8964FG3, EDO
25900.790.8558FG3, GOL
33280.640.8030GOL
4690.320.7514empty
5560.320.7616empty

Interfaces

1 interface between chains.

  • A–B · 1200 Ų buried · 25 hydrogen bonds · protein-protein

Compared structures

  • 3IUE · Crystal structure of pantothenate synthetase in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.